Status:
COMPLETED
Impact of Pacing Mode and Diastolic Function on Cardiac Output
Lead Sponsor:
Kepler University Hospital
Collaborating Sponsors:
Medtronic
Conditions:
Diastolic Function
Cardiac Output
Eligibility:
All Genders
18-99 years
Phase:
NA
Brief Summary
Background It is known from previous research that in patients with complete AV (atrioventricular) block and pacemaker stimulation stroke volume and cardiac output are higher with AV-synchronous than ...
Eligibility Criteria
Inclusion
- Patient is able and willing to give informed consent and is above the age of 18.
- Patient is implanted with a dual chamber pacemaker system for at least 6 weeks.
- Patient is in sinus rhythm on the day of recruitment.
- Patient has a ventricular pacing rate exceeding 90%.
- Upon initial device interrogation, parameters are within normal ranges.
- Calculated battery life is more than 1 year.
Exclusion
- Patient is not in sinus rhythm on the day of echo examination.
- Intrinsic ventricular activation on the day of echo examination.
- Relevant shunt on the atrial, ventricular or pulmonary level.
- Moderate or severe heart valve dysfunction (stenosis or regurgitation).
- Presence of other medical devices that may interact with the pacemaker system.
- Women who are pregnant or breast feeding.
Key Trial Info
Start Date :
June 26 2019
Trial Type :
INTERVENTIONAL
Allocation :
ACTUAL
End Date :
February 5 2020
Estimated Enrollment :
40 Patients enrolled
Trial Details
Trial ID
NCT04068233
Start Date
June 26 2019
End Date
February 5 2020
Last Update
February 21 2020
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Kepler University Hospital
Linz, Upper Austria, Austria, 4020